Acceder Registro /

María Rosa Moya Quiles

Buscador

Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Galian JA, Botella C, Moya-Quiles R, Muro-Perez M, Minguela A, Llorente S, Muro M. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines. 2024 Jan 5;12(1):116. doi: 10.3390/biomedicines12010116. PubMed PMID: 38255221.
AÑO: 2024; IF: 4.7
Cuenca I, Botella C, Moya-Quiles MR, Jimenez-Coll V, Galian JA, Martinez-Banaclocha H, Muro-Perez M, Minguela A, Legaz I, Muro M. Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain. Diagnostics (Basel). 2023 Sep 2;13(17):2845. doi: 10.3390/diagnostics13172845. PubMed PMID: 37685383; PubMed Central PMCID: PMC10486455.
AÑO: 2023; IF: 3.6
Moya-Quiles MR, Muro M. Identification of five new HLA-DQB1 intronic variants by next-generation sequencing. HLA. 2023 Jan 24. doi: 10.1111/tan.14977. Online ahead of print. PubMed PMID: 36693766.
AÑO: 2023; IF: 8.0
Jimenez-Coll V, Llorente S, Boix F, Alfaro R, Galian JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Muro-Perez M, Minguela A, Legaz I, Muro M. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome. Int J Mol Sci. 2023 Feb 15;24(4):3908. doi: 10.3390/ijms24043908. PubMed PMID: 36835314; PubMed Central PMCID: PMC9963702.
AÑO: 2023; IF: 5.6
Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, de la Pena-Moral J, Minguela A, Legaz I, Muro M. Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. Transplant Proc. 2023 Jan 6:S0041-1345(22)00883-1. doi: 10.1016/j.transproceed.2022.12.012. Online ahead of print. PubMed PMID: 36621349.
AÑO: 2023; IF: 0.9

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R